Racial differences in gout incidence in a population-based cohort: Atherosclerosis risk in communities study

American Journal of Epidemiology

Volumn 179, Issue 5, 2014, Pages 576-583

  Maynard, Janet W ^a   McAdams Demarco, Mara A ^a   Law, Andrew ^a   Kao, Linda ^a   Gelber, Allan C ^a   Coresh, Josef ^a   Baer, Alan N ^a  

^a NONE   (United States)

Author keywords

Gout; Inflammatory arthritis; Race; Uric acid

Indexed keywords

URIC ACID;

BLACK POPULATION; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; DISEASE INCIDENCE; HEALTH RISK; RACIAL DISPARITY; RISK ASSESSMENT; SERUM;

ADULT; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GOUT; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; RACE DIFFERENCE; RISK FACTOR; SEX DIFFERENCE; URIC ACID BLOOD LEVEL;

UNITED STATES;

GOUT; INFLAMMATORY ARTHRITIS; RACE; URIC ACID;

AFRICAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GOUT; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEX FACTORS; UNITED STATES; URIC ACID;

EID: 84896731715     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwt299     Document Type: Article

References (43)

1. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum. 2011;63(10):3136-3141.
2. Krishnan E, Lienesch D, Kwoh CK. Gout in ambulatory care settings in the United States. J Rheumatol. 2008;35(3):498-501.
3. Sundy JS, Hershfield MS. Uricase and other novel agents for the management of patients with treatment-failure gout. Curr Rheumatol Rep. 2007;9(3):258-264.
4. Halpern R, Mody RR, Fuldeore MJ, et al. Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis. Curr Med Res Opin. 2009;25(7):1711-1719.
5. Halpern R, Fuldeore MJ, Mody RR, et al. The effect of serum urate on gout flares and their associated costs: an administrative claims analysis. J Clin Rheumatol. 2009;15(1):3-7.
6. Singh JA. Quality of life and quality of care for patients with gout. Curr Rheumatol Rep. 2009;11(2):154-160.
7. Roddy E, ZhangW, Doherty M. Is gout associated with reduced quality of life? A case-control study. Rheumatology (Oxford). 2007;46(9):1441-1444.
8. Lawrence RC, Felson DT, Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008;58(1):26-35.
9. Choi HK, Atkinson K, Karlson EW, et al. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the Health Professionals Follow-up Study. Arch Intern Med. 2005; 165(7):742-748.
10. Choi HK, Atkinson K, Karlson EW, et al. Alcohol intake and risk of incident gout in men: a prospective study. Lancet. 2004; 363(9417):1277-1281.
11. Choi HK, Atkinson K, Karlson EW, et al. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med. 2004;350(11):1093- 1103.
12. Choi HK,WillettW, Curhan G. Coffee consumption and risk of incident gout in men: a prospective study. Arthritis Rheum. 2007;56(6):2049-2055.
13. Hochberg MC, Thomas J, Thomas DJ, et al. Racial differences in the incidence of gout. The role of hypertension. Arthritis Rheum. 1995;38(5):628-632.
14. Bhole V, de Vera M, Rahman MM, et al. Epidemiology of gout in women: fifty-two-year followup of a prospective cohort. Arthritis Rheum. 2010;62(4):1069-1076.
15. Juraschek SP, Miller ER 3rd, Gelber AC. Body mass index, obesity, and prevalent gout in the United States in 1988-1994 and 2007-2010. Arthritis Care Res. 2013;65(1):127-132.
16. Maynard JW, McAdams DeMarco MA, Baer AN, et al. Incident gout in women and association with obesity in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Med. 2012;125(7):717 e9-717 e17.
17. Arromdee E, Michet CJ,Crowson CS, et al. Epidemiology of gout: Is the incidence rising? J Rheumatol. 2002;29(11):2403-2406.
18. Roddy E, ZhangW, Doherty M. The changing epidemiology of gout. Nat Clin Pract Rheumatol. 2007;3(8):443-449.
19. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol. 1989;129(4):687-702.
20. McAdams MA, Maynard JW, Baer AN, et al. Reliability and sensitivity of the self-report of physician-diagnosed gout in the campaign against cancer and heart disease and the Atherosclerosis Risk in the Community cohorts. J Rheumatol. 2011;38(1):135-141.
21. Jackson R, Chambless LE, Yang K, et al. Differences between respondents and nonrespondents in a multicenter community-based study vary by gender ethnicity. The Atherosclerosis Risk in Communities (ARIC) study investigators. J Clin Epidemiol. 1996;49(12):1441-1446.
22. National Heart Lung and Blood Institute. Atherosclerosis Risk in Communitiesy Study. Operations Manual No. 2: Cohort Component Procedures, Version 1.0. Chapel Hill, NC: University of North Carolina School of Public Health; 1987.
23. National Heart Lung and Blood Institute. Atherosclerosis Risk in Communities Study. Operations Manual No. 11: Sitting Blood Pressure, Version 1.0. Chapel Hill, NC: University of North Carolina School of Public Health; 1987.
24. Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985;122(1):51-65.
25. Stevens J, Metcalf PA, Dennis BH, et al. Reliability of a food frequency questionnaire by ethnicity, gender, age, and education. Nutr Res. 1996;16(5):735-745.
26. National Heart Lung and Blood Institute. Atherosclerosis Risk in Communities Study. Operations Manual No. 10: Clinical Chemistry Determinations, Version 1.0. Chapel Hill, NC: University of North Carolina School of Public Health; 1987.
27. Iribarren C, Folsom AR, Eckfeldt JH, et al. Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: the ARIC Study. Atherosclerosis Risk in Communities. Ann Epidemiol. 1996;6(4):331-340.
28. Eckfeldt JH, Chambless LE, Shen YL. Short-term, within-person variability in clinical chemistry test results. Experience from the Atherosclerosis Risk in Communities Study. Arch Pathol Lab Med. 1994;118(5):496-500.
29. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150(9):604-612.
30. Astor BC, Arnett DK, Brown A, et al. Association of kidney function and hemoglobin with left ventricular morphology among African Americans: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2004;43(5): 836-845.
31. Manjunath G, Tighiouart H, Ibrahim H, et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol. 2003;41(1): 47-55.
32. Coresh J, Astor BC, McQuillan G, et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis. 2002;39(5):920-929.
33. Eriksson H, Caidahl K, Larsson B, et al. Cardiac and pulmonary causes of dyspnoea-validation of a scoring test for clinical-epidemiological use: the Study of Men Born in 1913. Eur Heart J. 1987;8(9):1007-1014.
34. Hertz-Picciotto I, Rockhill B. Validity and efficiency of approximation methods for tied survival times in Cox regression. Biometrics. 1977;53(3):1151-1156.
35. Hozawa A, Folsom AR, Ibrahim H, et al. Serum uric acid and risk of ischemic stroke: the ARIC Study. Atherosclerosis. 2006; 187(2):401-407.
36. Moriarity JT, Folsom AR, Iribarren C, et al. Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol. 2000;10(3): 136-143.
37. Gaffo AL, Jacobs DR Jr, Lewis CE, et al. Association between being African-American, serum urate levels and the risk of developing hyperuricemia: findings from the Coronary Artery Risk Development in Young Adults cohort. Arthritis Res Ther. 2012;14(1):R4.
38. Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med. 1987;82(3):421-426.
39. Dehghan A, Kottgen A, Yang Q, et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet. 2008;372(9654): 1953-1961.
40. Yang Q, Kottgen A, Dehghan A, et al. Multiple genetic loci influence serum urate and their relationship with gout and cardiovascular disease risk factors. Circ Cardiovasc Genet. 2010;3(6):523-530.
41. Kaufman JS, Cooper RS, McGee DL. Socioeconomic status and health in blacks and whites: the problem of residual confounding and the resiliency of race. Epidemiology. 1997; 8(6):621-628.
42. Kaufman JS. Epidemiologic analysis of racial/ethnic disparities: some fundamental issues and a cautionary example. Soc Sci Med. 2008;66(8):1659-1669.
43. Wallace SL, Robinson H, Masi AT, et al. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum. 1977;20(3):895-900.